A UK father and a widower have filed lawsuits against AstraZeneca PLC (LSE:AZN), claiming that the Oxford-AstraZeneca Covid-19 vaccine was defective and caused blood clots and brain injuries to their loved ones, according to reports.
Two court cases were filed by relatives of patients of the vaccine in the High Court who developed a rare and potentially deadly neurological condition, one of whom died, which imply the vaccine was “defective”.
Jamie Scott, a British father, got permanent brain damage from a blood clot following the jab, while Alpa Tailor died after developing blood clots associated with the vaccine.
The cases could lead to more than 80 damages claims totalling approximately £80 million over a rare condition, vaccine-induced Immune thrombocytopenia and thrombosis.
The vaccine was discontinued in the UK and Australia due to concerns over rare side effects, but the World Health Organization declared it safe and effective for all individuals aged 18 and above in 2022.
The case will also examine the UK government’s decision to grant indemnity for AstraZeneca in the event of any adverse reactions that could not have been foreseen.
AstraZeneca said the safety of patients is its highest priority and defended its vaccine’s efficacy and safety profile.